Benzinga | Jan 26, 2022 07:35AM EST

Abbott Laboratories Q4 EPS $1.32 Beats $1.21 Estimate, Sales $11.50B Beat $10.71B Estimate

Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.21 by 9.09 percent. This is a 8.97 percent decrease over earnings of $1.45 per share from the same period last year. The company reported quarterly sales of $11.50 billion which beat the analyst consensus estimate of $10.71 billion by 7.38 percent. This is a 7.47 percent increase over sales of $10.70 billion the same period last year.